Literature DB >> 10554333

Successful resection of metachronous liver metastasis from alpha-fetoprotein-producing gastric cancer: report of a case.

Y Sato1, T Nishimaki, K Date, Y Shirai, I Kurosaki, Y Saito, T Watanabe, K Hatakeyama.   

Abstract

We present herein the case of a 68-year-old man in whom metachronous liver metastasis from an alpha-fetoprotein (AFP)-producing gastric cancer was successfully treated. The patient initially underwent a distal gastrectomy for an AFP-producing gastric cancer on January 30, 1997, following which the serum AFP level which had been 228 ng/ml prior to surgery decreased to 30 ng/ml. However, 7 months after surgery, follow-up examination revealed an abnormal elevation of the serum AFP level up to 301 ng/ml, and a liver tumor was subsequently detected at segment 8 (S8) by abdominal ultra-sonography. There was no evidence of hepatitis B or C virus infections. After various investigations, he was diagnosed to have liver metastases in S6 and S8, from the AFP-producing gastric cancer, and a partial hepatectomy of S6 and S8 was performed. His postoperative course was uneventful and he was discharged on postoperative day 26. Thereafter, his serum AFP levels decreased and have remained within normal limits for 12 months since his operation. To the best of our knowledge, this is the first case of successful resection of metachronous liver metastasis from an AFP-producing gastric cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10554333     DOI: 10.1007/s005950050647

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  5 in total

1.  [Clinicopathological study of AFP producing gastric cancer--significance of AFP in gastric cancer].

Authors:  Y Takahashi; M Mai; T Ogino; H Ueda; K Sawaguchi; M Ueno
Journal:  Nihon Geka Gakkai Zasshi       Date:  1987-06

Review 2.  Resection of liver metastasis from alpha-fetoprotein-producing early gastric cancer: report of a case.

Authors:  T Tsurumachi; H Yamamoto; K Watanabe; I Honda; S Watanabe; S Yamada; K Jingu; D Satomi; M Fujita
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

3.  [Existence of alpha feto protein during gastric-origin secondary cancer of the liver].

Authors:  J Bourreille; P Metayer; F Sauger; F Matray; A Fondimare
Journal:  Presse Med       Date:  1970-06-06       Impact factor: 1.228

4.  Clinicopathologic features and long-term results of alpha-fetoprotein-producing gastric cancer.

Authors:  Y C Chang; N Nagasue; H Kohno; H Taniura; M Uchida; A Yamanoi; T Kimoto; T Nakamura
Journal:  Am J Gastroenterol       Date:  1990-11       Impact factor: 10.864

5.  Serum alpha-fetoprotein in patients with neoplasms of the gastrointestinal tract.

Authors:  K R McIntire; T A Waldmann; C G Moertel; V L Go
Journal:  Cancer Res       Date:  1975-04       Impact factor: 12.701

  5 in total
  3 in total

1.  Alpha-fetoprotein-producing early gastric cancer of the remnant stomach: report of a case.

Authors:  Yutaka Shibata; Kouhei Sato; Masashi Kodama; Hiroshi Nanjyo
Journal:  Surg Today       Date:  2007-10-25       Impact factor: 2.549

2.  Clinicopathological characteristics of alpha-fetoprotein-producing gastric cancer.

Authors:  Huan Chun; Sung Joon Kwon
Journal:  J Gastric Cancer       Date:  2011-03-31       Impact factor: 3.720

3.  Efficacy and safety of SOX chemotherapy with or without surgery in AFP-producing advanced gastric cancer.

Authors:  Zhu Li; Xu Hou; Juan Chen; Huidong Sun; Yuetang Mi; Yongling Sui; Yuhong Li; Jiaping Xie; Yingli Qiao; Xiaofeng Lei; Xiaoshuang Che; Jun Liu
Journal:  Oncol Lett       Date:  2017-05-24       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.